{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Albizia lebbeck", "Rosellinia sanctae-cruciana", "MTT assay", "cytochalasin", "endophytic fungi"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29573314", "DateCompleted": {"Year": "2018", "Month": "08", "Day": "29"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "05", "Day": "20"}], "Language": ["eng"], "ELocationID": ["10.1111/jam.13764"], "Journal": {"ISSN": "1365-2672", "JournalIssue": {"Volume": "125", "Issue": "1", "PubDate": {"Year": "2018", "Month": "Jul"}}, "Title": "Journal of applied microbiology", "ISOAbbreviation": "J Appl Microbiol"}, "ArticleTitle": "New cytochalasin from Rosellinia sanctae-cruciana, an endophytic fungus of Albizia lebbeck.", "Pagination": {"StartPage": "111", "EndPage": "120", "MedlinePgn": "111-120"}, "Abstract": {"AbstractText": ["To explore the potential of Rosellinia sanctae-cruciana an endophytic fungus associated with Albizia lebbeck for pharmaceutically important cytotoxic compounds.", "One novel cytochalasin, named jammosporin A (1) and four known analogues (2-5) were isolated from the culture of the endophytic fungus R. sanctae-cruciana, harboured from the leaves of the medicinal plant A. lebbeck. Their structures were elucidated by extensive spectroscopic analyses including one-dimensional and two-dimensional nuclear magnetic resonance data along with MS data and by comparison with literature reports. In preliminary screening the ethyl acetate extract of the fungal culture was tested for cytotoxic activity against a panel of four cancer cell lines (MOLT-4, A549, MIA PaCa-2 and MDA-MB-231), and found to be active against MOLT-4 with an IC<sub>50</sub> value of 10\u00a0\u03bcg\u00a0ml<sup>-1</sup> . Owing to the remarkable cytotoxic activity of the extract the isolated compounds (1-5) were evaluated for their cytototoxicity against the MOLT-4 cell line by MTT assay. Interestingly, compounds 1-2, 4 and 5 showed considerable cytotoxic potential against the human leukaemia cancer cell line (MOLT-4) with IC<sub>50</sub> values of 20\u00b70, 10\u00b70, 8\u00b70 and 6\u00b70\u00a0\u03bcmol\u00a0l<sup>-1</sup> , respectively, while compound 3 showed an IC<sub>50</sub> value of 25\u00a0\u03bcmol\u00a0l<sup>-1</sup> . This is the first report of the existence of this class of secondary metabolites in R. sanctae-cruciana fungus.", "This study discovered a novel compound, named jammosporin A, isolated for the first time from R. sanctae-cruciana, an endophytic fungus of A. lebbeck with anticancer activity against the MOLT-4 cell line.", "Rosellinia sanctae-cruciana represents an interesting source of a new compound with bioactive potential as a therapeutic agent against a human leukaemia cancer cell line (MOLT-4)."], "CopyrightInformation": "\u00a9 2018 The Society for Applied Microbiology."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbial Biotechnology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Jammu, India."}], "LastName": "Sharma", "ForeName": "N", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbial Biotechnology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India."}], "LastName": "Kushwaha", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbial Biotechnology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Jammu, India."}], "LastName": "Arora", "ForeName": "D", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Product Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India."}], "LastName": "Jain", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Product Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India."}], "LastName": "Singamaneni", "ForeName": "V", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India."}], "LastName": "Sharma", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioorganic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India."}], "LastName": "Shankar", "ForeName": "R", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India."}, {"Identifier": [], "Affiliation": "Indian Pharmacopoeia Commission, Ghaziabad, India."}], "LastName": "Bhushan", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Jammu, India."}, {"Identifier": [], "Affiliation": "Natural Product Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India."}], "LastName": "Gupta", "ForeName": "P", "Initials": "P"}, {"Identifier": ["0000-0002-5691-7980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbial Biotechnology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Jammu, India."}], "LastName": "Jaglan", "ForeName": "S", "Initials": "S"}], "DataBankList": [{"DataBankName": "GENBANK", "AccessionNumberList": ["GU292824", "KY006116"]}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Appl Microbiol", "NlmUniqueID": "9706280", "ISSNLinking": "1364-5072"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytochalasins"}], "MeshHeadingList": [{"QualifierName": ["microbiology"], "DescriptorName": "Albizzia"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology", "toxicity"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ascomycota"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology", "toxicity"], "DescriptorName": "Cytochalasins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": ["microbiology"], "DescriptorName": "Plant Leaves"}, {"QualifierName": ["microbiology"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2017", "Month": "10", "Day": "4"}, {"Year": "2017", "Month": "12", "Day": "26"}, {"Year": "2018", "Month": "3", "Day": "12"}, {"Year": "2018", "Month": "3", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "25", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29573314", "10.1111/jam.13764"]}}]}